Advertisement

Comparative Ultrastructural Analysis of D1 and D5 Dopamine Receptor Distribution in the Substantia Nigra and Globus Pallidus of Monkeys

  • Michele A. Kliem
  • Jean-Francois Pare
  • Zafar U. Khan
  • Thomas Wichmann
  • Yoland Smith
Conference paper
Part of the Advances in Behavioral Biology book series (ABBI, volume 58)

Abstract

Dopamine acts through the D1-like (D1, D5) and D2-like (D2, D3, D4) receptor families. Various studies have shown a preponderance of presynaptic dopamine D1 receptors on axons and terminals in the internal globus pallidus (GPi) and substantia nigra reticulata (SNr), but little is known about D5 receptors distribution in these brain regions. In order to further characterize the potential targets whereby dopamine could mediate its effects in basal ganglia output nuclei, we undertook a comparative electron microscopic analysis of D1 and D5 receptors immunoreactivity in the GPi and SNr of rhesus monkeys. At the light microscopic level, D1 receptor labeling was confined to small punctate elements, while D5 receptor immunoreactivity was predominantly expressed in cellular and dendritic processes throughout the SNr and GPi. At the electron microscopic level, 90% of D1 receptor labeling was found in unmyelinated axons or putative GABAergic terminals in both basal ganglia output nuclei. In contrast, D5 receptor labeling showed a different pattern of distribution. Although the majority (65–75%) of D5 receptor immunoreactivity was also found in unmyelinated axons and terminals in GPi and SNr, significant D5 receptor immunolabeling was also located in dendritic and glial processes. Immunogold studies showed that about 50% of D1 receptor immunoreactivity in axons was bound to the plasma membrane providing functional sites for D1 receptor-mediated effects on transmitter release in GPi and SNr. These findings provide evidence for the existence of extrastriatal pre- and postsynaptic targets through which dopamine and drugs acting at D1-like receptors may regulate the basal ganglia outflow and possibly exert some of their anti-parkinsonian effects.

Keywords

Unmyelinated Axon Parkinsonian Monkey Gaba Efflux Preterminal Axon Basal Ganglion Output Nucleus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Aceves J, Floran B, Sierra A and Mariscal S (1995) D-1 receptor mediated modulation of the release of gamma-aminobutyric acid by endogenous dopamine in the basal ganglia of the rat. Prog Neuropsychopharmacol Biol Psychiatry 19: 727–739.CrossRefPubMedGoogle Scholar
  2. Arsenault MY, Parent A, Seguela P and Descarries L (1988) Distribution and morphological characteristics of dopamine-immunoreactive neurons in the midbrain of the squirrel monkey (Saimiri sciureus). J Comp Neurol 267: 489–506.CrossRefPubMedGoogle Scholar
  3. Barone P, Bankiewicz KS, Corsini GU, Kopin IJ and Chase TN (1987) Dopaminergic mechanisms in hemiparkinsonian monkeys. Neurology 37: 1592–1595.PubMedGoogle Scholar
  4. Baufreton J, Garret M, Rivera A, de la Calle A, Gonon F, Dufy B, Bioulac B and Taupignon A (2003) D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J Neurosci 23: 816–825.PubMedGoogle Scholar
  5. Bergquist F, Shahabi HN and Nissbrandt H (2003) Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod. Brain Res 973: 81–91.CrossRefPubMedGoogle Scholar
  6. Bergson C, Mrzljak L, Smiley JF, Pappy M, Levenson R and Goldman-Rakic PS (1995) Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci 15: 7821–7836.PubMedGoogle Scholar
  7. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K and Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 20: 415–455.CrossRefPubMedGoogle Scholar
  8. Besson MJ, Graybiel AM and Nastuk MA (1988) [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: Delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience 26: 101–119.CrossRefPubMedGoogle Scholar
  9. Betarbet R and Greenamyre JT (2004) Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP. Exp Neurol 189: 393–403.CrossRefPubMedGoogle Scholar
  10. Björklund A and Lindvall O (1975) Dopamine in dendrites of substantia nigra neurons: Suggestions for a role in dendritic terminals. Brain Res 83: 531–537.CrossRefPubMedGoogle Scholar
  11. Blanchet PJ, Grondin R, Bedard PJ, Shiosaki K and Britton DR (1996) Dopamine D1 receptor desensitization profile in MPTP-lesioned primates. Eur J Pharmacol 309: 13–20.CrossRefPubMedGoogle Scholar
  12. Caille I, Dumartin B and Bloch B (1996) Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation. Brain Res 730: 17–31.PubMedGoogle Scholar
  13. Centonze D, Grande C, Saulle E, Martin AB, Gubellini P, Pavon N, Pisani A, Bernardi G, Moratalla R and Calabresi P (2003) Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J Neurosci 23: 8506–8512.PubMedGoogle Scholar
  14. Cheramy A, Leviel V and Glowinski J (1981) Dendritic release of dopamine in the substantia nigra. Nature 289: 537–542.CrossRefPubMedGoogle Scholar
  15. Choi WS, Machida CA and Ronnekleiv OK (1995) Distribution of dopamine D1, D2, and D5 receptor mRNAs in the monkey brain: Ribonuclease protection assay analysis. Brain Res 31: 86–94.CrossRefGoogle Scholar
  16. Ciliax BJ, Nash N, Heilman C, Sunahara R, Hartney A, Tiberi M, Rye DB, Caron MG, Niznik HB and Levey AI (2000) Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse 37: 125–145.CrossRefPubMedGoogle Scholar
  17. Clark D and White FJ (1987) D1 dopamine receptor – the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse 1: 347–388.CrossRefPubMedGoogle Scholar
  18. Dziewczapolski G, Menalled LB, Garcia MC, Mora MA, Gershanik OS and Rubinstein M (1998) Opposite roles of D1 and D5 dopamine receptors in locomotion revealed by selective antisense oligonucleotides. Neuroreport 9: 1–5.CrossRefPubMedGoogle Scholar
  19. Ferre S, O’Connor WT, Svenningsson P, Björklund L, Lindberg J, Tinner B, Stromberg I, Goldstein M, Ogren SO, Ungerstedt U, Fredholm BB and Fuxe K (1996) Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur J Neurosci 8: 1545–1553.CrossRefPubMedGoogle Scholar
  20. Floran B, Aceves J, Sierra A and Martinez-Fong D (1990) Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci Lett 116: 136–140.CrossRefPubMedGoogle Scholar
  21. Floran B, Barajas C, Floran L, Erlij D and Aceves J (2002) Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat. Neuroscience 115: 743–751.CrossRefPubMedGoogle Scholar
  22. Fremeau RT, Jr., Duncan GE, Fornaretto MG, Dearry A, Gingrich JA, Breese GR and Caron MG (1991) Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc Natl Acad Sci USA 88: 3772–3776.CrossRefPubMedGoogle Scholar
  23. Gagnon C, Bedard PJ and Di Paolo T (1990) Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists. Eur J Pharmacol 178: 115–120.CrossRefPubMedGoogle Scholar
  24. Geffen LB, Jessell TM, Cuello AC and Iversen LL (1976) Release of dopamine from dendrites in rat substantia nigra. Nature 260: 258–260.CrossRefPubMedGoogle Scholar
  25. Gerhardt GA, Cass WA, Huettl P, Brock S, Zhang Z and Gash DM (1999) GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys. Brain Res 817: 163–171.CrossRefPubMedGoogle Scholar
  26. Gnanalingham KK, Smith LA, Hunter AJ, Jenner P and Marsden CD (1993) Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: An autoradiographic study. Synapse 14: 184–194.CrossRefPubMedGoogle Scholar
  27. Goulet M and Madras BK (2000) D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys. J Pharmacol Exp Ther 292: 714–724.PubMedGoogle Scholar
  28. Graham WC, Sambrook MA and Crossman AR (1993) Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism. Brain Res 602: 290–303.CrossRefPubMedGoogle Scholar
  29. Grandy DK, Zhang Y, Bouvier C, Zhou QY, Johnson RA, Allen L, Buck K, Bunzow JR, Salon J and Civelli O (1991) Multiple human-D5 dopamine receptor genes - a functional receptor and 2 pseudogenes. Proc Natl Acad Sci USA 88: 9175–9179.CrossRefPubMedGoogle Scholar
  30. Hemsley KM and Crocker AD (2001) Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra. Neuropsychopharmacology 25: 514–526.CrossRefPubMedGoogle Scholar
  31. Hornykiewicz O and Kish SJ (1987) Biochemical pathophysiology of Parkinson’s disease. Adv Neurol 45: 19–34.PubMedGoogle Scholar
  32. Jan C, Francois C, Tande D, Yelnik J, Tremblay L, Agid Y and Hirsch E (2000) Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients. Eur J Neurosci 12: 4525–4535.PubMedGoogle Scholar
  33. Khan ZU, Gutierrez A, Martin R, Penafiel A, Rivera A and de la Calle A (2000) Dopamine D5 receptors of rat and human brain. Neuroscience 100: 689–699.CrossRefPubMedGoogle Scholar
  34. Kliem MA, Maidment NT, Ackerson LC, Chen S, Smith Y and Wichmann T (2007) Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys. J Neurophysiol 89: 1489–1500.CrossRefGoogle Scholar
  35. Levey AI, Kitt CA, Simonds WF, Price DL and Brann MR (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11: 3218–3226.PubMedGoogle Scholar
  36. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR and Ciliax BJ (1993) Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90: 8861–8865.CrossRefPubMedGoogle Scholar
  37. Mengod G, Vilaro MT, Niznik HB, Sunahara RK, Seeman P, O’Dowd BF and Palacios JM (1991) Visualization of a dopamine D1 receptor mRNA in human and rat brain. Brain Res 10: 185–191.CrossRefGoogle Scholar
  38. Neve KA (1997) The Dopamine Receptors. Totowa, NJ: Humana Press.Google Scholar
  39. Nieoullon A, Cheramy A and Glowinski J (1978) Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat. Brain Res 145: 69–83.CrossRefPubMedGoogle Scholar
  40. Pifl C, Bertel O, Schingitz G and Hornykiewicz O (1990) Extrastriatal dopamine in symptomatic and asymptomatic Rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurochem Int 17: 263–270.CrossRefPubMedGoogle Scholar
  41. Pifl C, Schingnitz G and Hornykiewicz O (1992) Striatal and non-striatal neurotransmitter changes in MPTP-parkinsonism in rhesus monkey: The symptomatic versus the asymptomatic condition. Neurochem Int 20(Suppl): 295S–297S.CrossRefPubMedGoogle Scholar
  42. Radnikow G and Misgeld U (1998) Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata. J Neurosci 18: 2009–2016.PubMedGoogle Scholar
  43. Richfield EK, Young AB and Penney JB (1987) Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. J Comp Neurol 262: 446–463.CrossRefPubMedGoogle Scholar
  44. Rosales MG, Martinez-Fong D, Morales R, Nunez A, Flores G, Gongora-Alfaro JL, Floran B and Aceves J (1997) Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: A microdialysis study. Neuroscience 80: 803–810.CrossRefPubMedGoogle Scholar
  45. Schneider JS and Rothblat DS (1991) Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats. Neuroscience 44: 421–429.CrossRefPubMedGoogle Scholar
  46. Sibley DR (1999) New insights into dopaminergic receptor function using antisense and genetically altered animals. Annu Rev Pharmacol Toxicol 39: 313–341.CrossRefPubMedGoogle Scholar
  47. Smith Y, Lavoie B, Dumas J and Parent A (1989) Evidence for a distinct nigropallidal dopaminergic projection in the squirrel monkey. Brain Res 482: 381–386.CrossRefPubMedGoogle Scholar
  48. Starr PA, Wichmann T, van Horne C and Bakay RA (1999) Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey. Cell Transplant 8: 37–45.PubMedGoogle Scholar
  49. Sunahara RK, Guan HC, Odowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Vantol HHM and Niznik HB (1991) Cloning of the gene for a human dopamine D5-Receptor with higher affinity for dopamine than D1. Nature 350: 614–619.CrossRefPubMedGoogle Scholar
  50. Tiberi M, Jarvie KR, Silvia C, Falardeau P, Gingrich JA, Godinot N, Bertrand L, Yangfeng TL, Fremeau RT and Caron MG (1991) Cloning, molecular characterization, and chromosomal assignment of a gene encoding a 2nd D1 dopamine receptor subtype - differential expression pattern in rat-brain compared with the D1a receptor. Proc Natl Acad Sci USA 88: 7491–7495.CrossRefPubMedGoogle Scholar
  51. Timmerman W and Abercrombie ED (1996) Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects. Synapse 23: 280–291.CrossRefPubMedGoogle Scholar
  52. Timmerman W and Westerink BH (1995) Extracellular gamma-aminobutyric acid in the substantia nigra reticulata measured by microdialysis in awake rats: Effects of various stimulants. Neurosci Lett 197: 21–24.CrossRefPubMedGoogle Scholar
  53. Trevitt JT, Carlson BB, Nowend K and Salamone JD (2001) Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat. Psychopharmacology 156: 32–41.CrossRefPubMedGoogle Scholar
  54. Trevitt T, Carlson B, Correa M, Keene A, Morales M and Salamone D (2002) Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: Neurochemical and behavioral studies. Psychopharmacology 159: 229–237.CrossRefPubMedGoogle Scholar
  55. Waszczak BL, Lee EK, Tamminga CA and Walters JR (1984) Effect of dopamine system activation on substantia nigra pars reticulata output neurons: Variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned rats. J Neurosci 4: 2369–2375.PubMedGoogle Scholar
  56. Weick BG and Walters JR (1987) Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Brain Res 405: 234–246.CrossRefPubMedGoogle Scholar
  57. Whone AL, Moore RY, Piccini PP and Brooks DJ (2003) Plasticity of the nigropallidal pathway in Parkinson’s disease. Ann Neurol 53: 206–213.CrossRefPubMedGoogle Scholar
  58. Windels F and Kiyatkin EA (2006) Dopamine action in the substantia nigra pars reticulata: Iontophoretic studies in awake, unrestrained rats. Eur J Neurosci 24: 1385–1394.CrossRefPubMedGoogle Scholar
  59. Yan Z and Surmeier DJ (1997) D5 dopamine receptors enhance Zn2+-sensitive GABA(A) currents in striatal cholinergic interneurons through a PKA/PP1 cascade. Neuron 19: 1115–1126.CrossRefPubMedGoogle Scholar
  60. Yung KK, Bolam JP, Smith AD, Hersch SM, Ciliax BJ and Levey AI (1995) Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy. Neuroscience 65: 709–730.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Michele A. Kliem
    • 1
  • Jean-Francois Pare
    • 1
  • Zafar U. Khan
    • 1
  • Thomas Wichmann
    • 1
  • Yoland Smith
    • 1
  1. 1.Yerkes National Primate Research CenterEmory UniversityAtlantaUSA

Personalised recommendations